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the studied mouse lines of additional genetic modifications that affect expression of
genes located in a close proximity to the alpha-synuclein-encoding   Snca   gene
makes these data open to various interpretations. To unambiguously demonstrate that
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study we revealed no loss of dopaminergic neurons following conditional inactivation of
the   Snca   gene in neurons of adult mice. Taken together, these results strongly
suggest that alpha-synuclein is required for efficient survival or maturation of
dopaminergic neurons in the developing SNpc but is dispensable for survival of mature
SNpc dopaminergic neurons.
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Abstract  
Previous studies of the alpha-synuclein null mutant mice on the C57Bl6 genetic background 
have revealed reduced number of dopaminergic neurons in their substantia nigra pars 
compacta (SNpc). However, the presence in genomes of the studied mouse lines of additional 
genetic modifications that affect expression of genes located in a close proximity to the 
alpha-synuclein-encoding Snca gene makes these data open to various interpretations. To 
unambiguously demonstrate that the absence of alpha-synuclein is the primary cause of the 
observed deficit of dopaminergic neurons, we employed a recently produced constituent 
alpha-synuclein knockout mouse line B6(Cg)-Sncatm1.2Vlb/J. The only modification introduced 
to the genome of these mice is a substitution of the first coding exon and adjusted short 
intronic fragments of the Snca gene by a single loxP site. We compared the number of 
dopaminergic neurons in the SNpc of this line, previously studied B6(Cg)-Sncatm1Rosl/J line 
and wild type littermate mice. A similar decrease was observed in both knockout lines when 
compared with wild type mice. In a recently published study we revealed no loss of 
dopaminergic neurons following conditional inactivation of the Snca gene in neurons of adult 
mice. Taken together, these results strongly suggest that alpha-synuclein is required for 
efficient survival or maturation of dopaminergic neurons in the developing SNpc but is 
dispensable for survival of mature SNpc dopaminergic neurons. 
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Background 
Gain-of-function of alpha-synuclein has been strongly linked to aetiology and pathogenesis 
of Parkinson’s and several other neurodegenerative diseases (recent advances and 
perspectives are summarised in Ref [1]). However, despite a growing body of evidence that 
suggests its involvement in many important molecular processes in healthy neurons, 
predominantly in presynaptic terminals (for recent review see Ref [2]), it is not clear if alpha-
synuclein was required for survival and/or maturation of neurons. Previous studies have 
demonstrated that at least on the C57Bl6 genetic background, adult mice lacking alpha-
synuclein as the result of a naturally occurred mutation or targeted inactivation of the 
encoded gene have reduced complement of dopaminergic neurons in their SNpc [3-7]. This 
deficiency becomes already evident in E12.5 embryonic brains and is not progressive [3, 4, 
7]. An uncertainty in interpretation of these results is due to a possibility that some additional 
genetic modifications present in both mouse lines used in these studies, rather than the absent 
of alpha-synuclein per se, could potentially cause partial loss of dopaminergic neurons. A 
naturally occurred deletion in the genome of Harlan UK C57Bl6 mice spans over 
approximately 350 kilobases, which causes the loss of function not only of alpha-synuclein 
encoded Snca, but also of several other genes [8]. Mice of B6(Cg)-Sncatm1Rosl/J line [9, 10] 
were produced by homologous recombination that resulted in a substitution of Snca exons by 
a neo expression cassette, which presence dramatically activate neuronal expression of a 
neighbouring Mmrn1 gene encoding multimerin 1, a protein whose function in the nervous 
system is enigmatic (Additional file 1). To avoid any disparity in the interpretation of data 
obtained in different mouse models and reaffirm that the loss of alpha-synuclein is the 
primary cause of the deficit of dopaminergic neurons in the substantia nigra of null mutant 
mice, we employed a line of mice with a “clean knockout” of alpha-synuclein. This B6(Cg)-
Sncatm1.2Vlb/J line has recently been produced in our laboratory by Cre-driven recombination 
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in the genome of “floxed” and neo-free mice of B6(Cg)-Sncatm1.1Vlb/J line followed by crosses 
with C57Bl6J mice to eliminate the CMV-Cre transgenic cassette. Therefore, the only foreign 
DNA sequence remaining in the genome of B6(Cg)-Sncatm1.2Vlb/J mice is a single loxP site 
substituting the first coding exon of Snca gene and some adjusted short intronic sequences. 
This genetic modification completely abolishes production of alpha-synuclein in homozygous 
animals [11]. 
Methods 
Null mutant and wild type littermates were produced by intercrossing of heterozygous 
animals and genotyped as described elsewhere [9, 10]. Brains of 4-month old male mice we 
fixed, histological sections prepared and immunostained with antibody against tyrosine 
hydroxylase (TH, mouse monoclonal antibody, clone TH-2, Sigma diluted 1:1000); TH-
positive neurons in the SNpc were stereologically counted as described previously [3, 4, 6].  
Results and Discussion 
Our morphometric analysis revealed that the total number of dopaminergic neurons in the 
SNpc of adult B6(Cg)-Sncatm1Rosl/J mice was 18±5.7% lower than in the SNpc of wild type 
mice (Fig. 1, an additional Excel file, Additional file 2, shows raw count data). This is 
consistent with the previously reported data for this line as well as for Harlan UK C57Bl6 
alpha-synuclein null mutant line [3-6]. Importantly, a similar reduction (23±7.0%) was found 
in the SNpc of a new “clean knockout” B6(Cg)-Sncatm1.2Vlb/J line (Fig. 1). The latter result 
clearly implies that dopaminergic neuron deficit observed in studied alpha-synuclein null 
mutant mouse lines is indeed caused by the lack of alpha-synuclein. 
In another recent study we have demonstrated that inactivation of Snca gene by the same 
genetic modification as in B6(Cg)-Sncatm1.2Vlb/J line but induced by Cre recombination in 
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neurons of adult or ageing B6(Cg)-Sncatm1.1Vlb/J animals, caused complete depletion of alpha-
synuclein from the dorsal striatum, a brain region where presynaptic terminals (i.e. sites of 
the predominant localisation of this protein) of the SNpc dopaminergic neurons are located. 
However, such a late-onset depletion did not lead to any loss of SNpc dopaminergic neurons 
[12]. Taken together, results of our two studies strongly suggest that alpha-synuclein is 
required for efficient survival or maturation of dopaminergic neurons in the developing SNpc 
but is dispensable for survival of mature SNpc dopaminergic neurons. It is also cannot be 
currently excluded that a certain population of developing dopaminergic neurons is 
particularly sensitive to the absence of alpha-synuclein.  
 
List of abbreviations 
SNpc - substantia nigra pars compacta  
TH - tyrosine hydroxylase 
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 Figure legend 
Figure 1. Similar decrease in the number of dopaminergic neurons in SNpc of two 
alpha-synuclein knockout lines. 
a) The number of TH-positive neurons in the SNpc of 4-month old wild type (WT), B6(Cg)- 
Sncatm1.2Vlb/J alpha-synuclein null (SncaVlb) and B6(Cg)-Sncatm1Rosl/J alpha-synuclein null 
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(SncaRosl) mice. Bar charts show mean±SEM of numbers of stereologically counted neurons 
in SNpc of 8 animals for each genotype. Statistical analysis using one-way ANOVA with 
Dunnett's multiple comparisons test revealed significant difference between WT and each of 
null mutant mouse groups (F (2, 45) = 4.854; p=0.0123; **p=0.0094; * p=0.0451), whereas 
the difference between two null mutant mouse groups was not significant (p=0.5329). b) 
Representative images of brain sections through SNpc region immunostained with antibody 
against TH. 
 
Additional material 
File name: Additional file 1 
File format: PDF (.pdf) 
Title of data: Expression levels of Mmrn1 mRNA in the cerebral cortex of wild type and 
synuclein null mutant mice 
Description of data: Bar chart shows relatives level of Mmrn1 mRNA in the cerebral cortex 
of the wild type (WT), B6(Cg)- Sncatm1.2Vlb/J alpha-synuclein null (SncaVlb) and B6(Cg)-
Sncatm1Rosl/J alpha-synuclein null (SncaRosl) mice estimated by real-time quantitative RT-
PCR.    
 
File name: Additional file 2 
File format: Excel file (.xlsx) 
Title of data: Number of TH-positive neurons in SNpc of wild type and synuclein null mutant 
mice 
Description of data: Raw data for neurons number counts in the left and right SNpc of 
individual animals used in the study.    
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